These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8013282)

  • 21. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.
    Kaiser R; Sezer O; Papies A; Bauer S; Schelenz C; Tremblay PB; Possinger K; Roots I; Brockmöller J
    J Clin Oncol; 2002 Jun; 20(12):2805-11. PubMed ID: 12065557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
    Tyndale RF; Sunahara R; Inaba T; Kalow W; Gonzalez FJ; Niznik HB
    Mol Pharmacol; 1991 Jul; 40(1):63-8. PubMed ID: 1857341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6.
    Fischer V; Vogels B; Maurer G; Tynes RE
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1355-60. PubMed ID: 1545398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro characterization of cytochrome P450 catalysed metabolism of the antiemetic tropisetron.
    Firkusny L; Kroemer HK; Eichelbaum M
    Biochem Pharmacol; 1995 Jun; 49(12):1777-84. PubMed ID: 7598739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
    Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
    Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man.
    Boobis AR; Murray S; Kahn GC; Robertz GM; Davies DS
    Mol Pharmacol; 1983 Mar; 23(2):474-81. PubMed ID: 6220203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.
    Halliday RC; Jones BC; Smith DA; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):369-78. PubMed ID: 8554939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of serotonin-3 receptor antagonists on cytochrome P450 activities in human liver microsomes.
    Niwa T; Yamamoto S; Saito M; Kobayashi N; Ikeda K; Noda Y; Takagi A
    Biol Pharm Bull; 2006 Sep; 29(9):1931-5. PubMed ID: 16946512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
    Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
    Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.
    Royer I; Monsarrat B; Sonnier M; Wright M; Cresteil T
    Cancer Res; 1996 Jan; 56(1):58-65. PubMed ID: 8548776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A.
    Voorman RL; Maio SM; Hauer MJ; Sanders PE; Payne NA; Ackland MJ
    Drug Metab Dispos; 1998 Jul; 26(7):631-9. PubMed ID: 9660845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.
    Yasui-Furukori N; Hidestrand M; Spina E; Facciolá G; Scordo MG; Tybring G
    Drug Metab Dispos; 2001 Oct; 29(10):1263-8. PubMed ID: 11560868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative metabolism of cinobufagin in liver microsomes from mouse, rat, dog, minipig, monkey, and human.
    Ma XC; Ning J; Ge GB; Liang SC; Wang XL; Zhang BJ; Huang SS; Li JK; Yang L
    Drug Metab Dispos; 2011 Apr; 39(4):675-82. PubMed ID: 21205911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites.
    Ching MS; Blake CL; Ghabrial H; Ellis SW; Lennard MS; Tucker GT; Smallwood RA
    Biochem Pharmacol; 1995 Sep; 50(6):833-7. PubMed ID: 7575645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6.
    Masimirembwa CM; Hasler JA; Johansson I
    Eur J Clin Pharmacol; 1995; 48(1):35-8. PubMed ID: 7621845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gliclazide hydroxylation by rat liver microsomes.
    Rieutord A; Stupans I; Shenfield GM; Gross AS
    Xenobiotica; 1995 Dec; 25(12):1345-54. PubMed ID: 8719909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of electrospray ionization liquid chromatography-mass spectrometry to study the role of CYP2D6 in the in vitro metabolism of 5-hydroxytryptamine receptor antagonists.
    Sanwald P; David M; Dow J
    J Chromatogr B Biomed Appl; 1996 Mar; 678(1):53-61. PubMed ID: 8861656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
    Ewald AH; Maurer HH
    Toxicol Lett; 2008 Dec; 183(1-3):52-7. PubMed ID: 18938231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro.
    Eagling VA; Wiltshire H; Whitcombe IW; Back DJ
    Xenobiotica; 2002 Jan; 32(1):1-17. PubMed ID: 11824416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron.
    Tzvetkov MV; Saadatmand AR; Bokelmann K; Meineke I; Kaiser R; Brockmöller J
    Pharmacogenomics J; 2012 Feb; 12(1):22-9. PubMed ID: 20921968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.